Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation.
about
Complement fragment 3a priming of umbilical cord blood progenitors: safety profile.Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) CollaborativeA preclinical model of double- versus single-unit unrelated cord blood transplantation.An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.How I treat: the selection and acquisition of unrelated cord blood grafts.Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long-term engraftment in NSG mice.Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units.Correlation of infused CD3+CD8+ cells with single-donor dominance after double-unit cord blood transplantation.The use of back-up units to enhance the safety of unrelated donor cord blood transplantationBetter allele-level matching improves transplant-related mortality after double cord blood transplantation.Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.The Role of HLA in Cord Blood Transplantation.Factors predicting single-unit predominance after double umbilical cord blood transplantation.Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantationDevelopment and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assayFrequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.Early CD3 peripheral blood chimerism predicts the long-term engrafting unit following myeloablative double-cord blood transplantation.Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning."No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment.Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodiesClinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in Korea.An overview of the progress on double umbilical cord blood transplantation.Blood stem cell products: toward sustainable benchmarks for clinical translation.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.The Assessment of Parameters Affecting the Quality of Cord Blood by the Appliance of the Annexin V Staining Method and Correlation with CFU Assays.Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells.Double cord blood transplantation: co-operation or competition?Indiscernible Benefit of Double-Unit Umbilical Cord Blood Transplantation in Children: A Single-Center Experience From Hong Kong.Stem cell therapeutics--reality versus hype and hope.Storage time affects umbilical cord blood viability.Validation of human monoclonal HLA Class I antibodies to evaluate the kinetics of donor chimerism in different cell subsets after double-cord-blood transplantation in the NOD/SCID model.Double vs. single cord blood transplantation in adolescent and adult hematological malignancies with heavier body weight (≥50 kg).Evaluation of the impact of banking umbilical cord blood units with high cell dose for ethnically diverse patients.A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies.
P2860
Q30366297-F0055E66-5EAE-44EC-B416-57BC3AE8576EQ33456839-D4956002-14C7-4FF2-AE40-4ADD24EF6D40Q33926045-5AE99115-7CBD-44E3-890F-399D0C301D6FQ33965521-2A6B4D4B-BA26-493B-9E2B-6D24EA1CA121Q34310952-67E675DA-8E32-4502-B30F-13EC41997FC4Q34463602-B1DEF17C-0D21-4CC1-AD51-CFDA87EA97A8Q34707580-57512917-90F4-4121-8757-EEC5CF158B45Q34751263-C6380FF0-4FA5-4F61-B45D-48C4752436E0Q34754318-6DB27551-2955-4FC4-BB62-7E9791163A8AQ35167190-F460790A-B09A-44C9-86D3-03F2F88DC666Q35219180-503A865E-AA5C-47CF-8BF2-63989F4FB2A7Q35711969-E35C1BA8-4D38-424F-AD85-7E131836C591Q35830784-F526FE68-5A6D-478C-A857-48D20EE23C18Q36115699-E03B0606-E610-488E-A8D1-CECD3F43BBFAQ36157327-4F5B451B-8955-4AFF-9627-5C1E0D89CB00Q36336608-FB08A290-7E6E-470E-862A-9DD612BD40E1Q36664471-746BBE21-1376-4EC1-8D35-7D976ECB0827Q36746512-E54D7300-6A79-4F1C-87A8-604BE7AB8A03Q36890805-FD6E4C79-174D-448E-B46A-75C85A7698D3Q36897147-0907AA5C-B6D3-4AD7-BA08-4ABE4C3F3FFCQ36902123-D12A9F2F-636A-4D14-82AD-5E82BE03212AQ36923420-3C141852-BEC6-44CC-A967-15EE4232ED3FQ37424438-F77CF922-5957-44C9-BD3E-D21F5CEBD412Q37674034-22DBBA8D-C71A-4A07-9D7A-7E77D84F057DQ37674071-5388B943-D1A6-4FDA-84DC-8A24296A67A2Q37699562-E2804442-2AB7-4CEA-963A-0AF67A459589Q37725142-334ABE56-C8F2-4282-8E13-7243772A87C9Q37872506-C05EDEAC-F1B3-4FDA-8A8D-C44B745239E3Q38072649-E4F760AE-52D6-444F-AB6A-F95D7DC67553Q38747929-4C857E92-4058-4FEB-8353-31B148D29EAEQ39246024-E6786D17-F661-4DF2-B8EE-5A799A06D417Q39505754-186A26ED-4F4E-474F-B972-B77ADA3DC021Q39805764-E3B55404-492F-4D2D-AA65-59D956132938Q40472138-51DE3293-F0A0-4E35-97DF-C29185F3D726Q42697968-990E141D-25ED-45B3-9A8E-D12FCE149A52Q43977542-A869E11F-9887-4F1F-846F-4A9049169184Q44792246-C9123356-6D9F-4ED4-AC46-AD632D800688Q47195077-0C822E72-2865-452A-AA47-20B556FD1DE5Q47384522-EF62DC9C-D872-4734-A921-A476F486D215Q48134193-9A29FBFF-36E3-437F-BD53-C2C194EADAE8
P2860
Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Cord blood units with low CD34 ...... r double unit transplantation.
@ast
Cord blood units with low CD34 ...... r double unit transplantation.
@en
type
label
Cord blood units with low CD34 ...... r double unit transplantation.
@ast
Cord blood units with low CD34 ...... r double unit transplantation.
@en
prefLabel
Cord blood units with low CD34 ...... r double unit transplantation.
@ast
Cord blood units with low CD34 ...... r double unit transplantation.
@en
P2093
P2860
P1476
Cord blood units with low CD34 ...... r double unit transplantation.
@en
P2093
Allison Schaible
Andromachi Scaradavou
James W Young
Juliet N Barker
Katherine M Smith
Michelle Abboud
Rebecca Hawke
P2860
P304
P356
10.1016/J.BBMT.2009.11.013
P577
2009-11-22T00:00:00Z